About iNCOVACC:
- It is developed by Bharat Biotech International Limited.
- It was developed in partnership with Washington University, St Louis, which had designed and developed the recombinant adenoviral vectored construct and evaluated in pre-clinical studies for efficacy.
- The approval is under Restricted Use in Emergency Situation for ages 18 and above in India, for heterologous booster doses.
- iNCOVACC is a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised SARS-CoV-2 spike protein.
- It is the world’s first intranasal vaccine to receive both primary series and heterologous booster approval.
- The vaccine candidate was evaluated in Phases I, II and III clinical trials with successful results and has been specifically formulated to allow intranasal delivery through nasal drops.
- It is stable at 2-8 degrees Celsius for easy storage and distribution.
Source : All India Radio
Last updated on Sep, 2026
→ UPSC 2027 Notification will be released on 13 January 2027 at upsconline.nic.in.
→ Asian Games 2026 are being held in Aichi-Nagoya, Japan, from 19 September to 4 October.
→ Check out the latest UPSC Syllabus here.
→ Download UPSC Model Answers for Mains 2026
→ UPSC Mains Question Paper 2026 is out now for Essay & GS Paper 1, 2, 3 & 4.
→ UPSC Calendar 2027 has been released.
→ Enroll in Vajiram & Ravi’s UPSC Mains Test Series 2027 for structured answer writing practice, expert evaluation, and exam-oriented feedback.
→ Join Vajiram & Ravi’s UPSC Mentorship Program 2027 for personalized guidance, strategy planning, and one-to-one support from experienced mentors.
→ Go through the UPSC Mains Previous Year Papers to enhance your preparation.
→ UPSC has released UPSC Toppers List 2025 with the Civil Services final result on its official website.
→ Also check Best UPSC Coaching in India
